BTK Inhibitors Versus Venetoclax as First- or Second-Line Therapy in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Real-World Evidence Study

Roeker LE, Han Y, Teschemaker A, Mato AR, Thompson MC
У данной статьи нет абстракта.
American journal of hematology, 2025-04-03